EUVIMEDDescubrir EUVIMED
Crossref

Magnoliae flos Overcomes EGFR ‐ TKI Resistance in NSCLC by Enhancing EGFR Ubiquitination

Qing Wu, Qi Su, Man Zhu iD, Tianfeng Yang, Wenjuan Tang, Yu Hu, Jiayan Ren, Xiuhong Peng, Suyu Zhang, Yanmin Zhang

Phytotherapy Research · 2026-06 · 40 (6) · 3613-3627

DOI: 10.1002/ptr.70311 ↗

At a glance

Journal article in Phytotherapy Research, published online on 2026-04-08. Written by Qing Wu and 9 co-authors. Institution: Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, China. Major MEDLINE topics: Carcinoma, Non-Small-Cell Lung, Drug Resistance, Neoplasm, Lung Neoplasms, Protein Kinase Inhibitors. 39 references. Funded by: National Natural Science Foundation of China, Shaanxi Province Science and Technology Development Plan Project, Shaanxi Province Science Fund for Distinguished Young Scholars.

ResumenSubjectsDatos bibliográficosCiteRelated studies

Abstract (original language)

Resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) remains a significant obstacle in treating non‐small cell lung cancer (NSCLC). There is an urgent need for novel therapeutic approaches to overcome such resistance. This study aimed to investigate the potential of Magnoliae flos (MF) to reverse EGFR–TKI resistance and to elucidate its underlying molecular mechanisms. Network pharmacology was employed to predict the anti‐NSCLC potential and molecular targets of MF. Predictions were validated through in vitro and in vivo experiments, including cell viability assays, flow cytometry for apoptosis and cell‐cycle analysis, wound‐healing assays, hierarchical extraction, high‐performance liquid chromatography‐mass spectrometry (HPLC‐MS), Western blotting, small‐molecule inhibitor screening, and patient‐derived xenograft (PDX) models. Bioinformatics analyses were conducted to identify signaling pathways associated with EGFR‐TKI resistance. Bioinformatics analysis suggested that MF modulates signaling pathways implicated in EGFR‐TKI resistance. In the PDX model of EGFR‐TKI‐resistant NSCLC, the chloroform layer extract of MF (Ext. C) significantly suppressed tumor growth. Ext. C inhibited the EGFR/PI3K/AKT pathway, reduced EGFR protein expression, induced apoptosis, arrested the cell cycle, and impaired cell migration. HPLC‐MS analysis identified magnolin (Mag), fargesin (Far), and kobusin (Kob) as bioactive compounds. Functional assays demonstrated these monomers exerted a synergistic anti‐tumor effect, with Mag showing the greatest potency. Small‐molecule inhibitor screening further revealed that Mag shortened the half‐life of EGFR by promoting its ubiquitination and degradation. MF and its active constituents exhibit potent anti‐tumor activity against EGFR‐TKI‐resistant NSCLC by promoting EGFR ubiquitination and downregulation of the EGFR/PI3K/AKT pathway. These findings suggest MF as a promising therapeutic candidate for overcoming EGFR‐TKI resistance and provide a basis for further preclinical development.

Subjects

MeSH terms (MEDLINE)

Carcinoma, Non-Small-Cell LungDrug Resistance, NeoplasmLung NeoplasmsProtein Kinase InhibitorsPlant ExtractsErbB ReceptorsHumansAnimalsUbiquitinationCell Line, TumorSignal TransductionApoptosisMiceMice, NudeXenograft Model Antitumor AssaysPhosphatidylinositol 3-KinasesNetwork PharmacologyFlowersAntineoplastic Agents, PhytogenicProto-Oncogene Proteins c-akt

Author keywords

Magnoliae flosEGFRNSCLCresistanceubiquitination

Substances

ErbB ReceptorsProtein Kinase InhibitorsEGFR protein, humanPlant ExtractsPhosphatidylinositol 3-KinasesAntineoplastic Agents, PhytogenicProto-Oncogene Proteins c-akt

Authors and institutions

  • Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, China.
  • School of Pharmacy, Health Science Center, Xi'an Jiaotong University, China.
  • State Key Laboratory of Shaanxi for Natural Medicines Research and Engineering, China.

ORCID profiles: Man Zhu

Funding

  • National Natural Science Foundation of China
  • Shaanxi Province Science and Technology Development Plan Project
  • Shaanxi Province Science Fund for Distinguished Young Scholars

Cite

APA

Wu, Q., Su, Q., Zhu, M., Yang, T., Tang, W., Hu, Y., Ren, J., Peng, X., Zhang, S., & Zhang, Y. (2026). Magnoliae flos Overcomes EGFR ‐ TKI Resistance in NSCLC by Enhancing EGFR Ubiquitination. Phytotherapy Research, 40(6), 3613-3627. https://doi.org/10.1002/ptr.70311

Vancouver

Wu Q, Su Q, Zhu M, Yang T, Tang W, Hu Y, et al. Magnoliae flos Overcomes EGFR ‐ TKI Resistance in NSCLC by Enhancing EGFR Ubiquitination. Phytotherapy Research. 2026;40(6):3613-3627. doi:10.1002/ptr.70311

BibTeX
@article{Wu2026,
  author = {Wu, Qing and Su, Qi and Zhu, Man and Yang, Tianfeng and Tang, Wenjuan and Hu, Yu and Ren, Jiayan and Peng, Xiuhong and Zhang, Suyu and Zhang, Yanmin},
  title = {Magnoliae flos Overcomes EGFR ‐ TKI Resistance in NSCLC by Enhancing EGFR Ubiquitination},
  journal = {Phytotherapy Research},
  year = {2026},
  volume = {40},
  number = {6},
  pages = {3613--3627},
  doi = {10.1002/ptr.70311}
}
Start for free →